CLASS II ONGOING Device recall · Reported 8 Feb 2023 · FDA Enforcement Report

Biopsy Medium, Reference Number 10620010 A, used recalled

CooperSurgical is recalling Biopsy Medium, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage, distributed in Georgia. The recall was initiated on 15 Dec 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot Number: 220506-006557
Quantity recalled489 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1044-2023
FDA event ID
91438
Recalling firm
CooperSurgical, Trumbull, CT
Classification
Class II
Status
Ongoing
Recall initiated
15 Dec 2022
FDA classified
31 Jan 2023
Reported
8 Feb 2023
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

15 Dec 2022Recall initiated by company
31 Jan 2023Classified by FDA+47 days
8 Feb 2023Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

The affected product may contain a medium other than the Biopsy Medium. There is a risk that use of the Product from this lot could cause degradation of the embryo.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

BIOPSY MEDIUM 10ML, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage embryos for Pre-implantation Genetic Diagnosis (PGD)

Where it was distributed

Global Distribution including countries of: Bahrain, Belgium, Bulgaria, Egypt, France, Georgia, Greece, Hong Kong, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Kuwait, Lebanon, Libya, Nigeria, Oman, Pakistan, Poland, Republic of North Macedonia, Saudi Arabia, Slovenia, Spain, Thailand, Turkey, Turkmenistan, and United Arab Emirates.

Georgia

Questions about this recall

Is Biopsy Medium, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage recalled?

Yes. CooperSurgical recalled Biopsy Medium, Reference Number 10620010 A, used for blastomere biopsy of cleavage stage on 15 Dec 2022. The recall is Class II and its status is Ongoing. Recall number Z-1044-2023.

Why was it recalled?

The affected product may contain a medium other than the Biopsy Medium. There is a risk that use of the Product from this lot could cause degradation of the embryo.

Which lots are affected?

Lot Number: 220506-006557

Where was it sold?

Global Distribution including countries of: Bahrain, Belgium, Bulgaria, Egypt, France, Georgia, Greece, Hong Kong, Iran, Iraq, Israel, Japan, Jordan, Kazakhstan, Kuwait, Lebanon, Libya, Nigeria, Oman, Pakistan, Poland, Republic of North Macedonia, Saudi Arabia, Slovenia, Spain, Thailand, Turkey, Turkmenistan, and United Arab Emirates.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from CooperSurgical

All 84

Other Other Medical Devices recalls

All 13,778